ALT Altimmune, Inc.
Altimmune, Inc. (ALT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 13, 2026 , by Durso Jerome Benedict .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Durso Jerome Benedict | President and CEO | Buy | 15,000 | $2.95 | $44.3K | 62,500 | |
| GILL JOHN | Director | Buy | 9,200 | $3.41 | $31.3K | 21,700 | |
| Durso Jerome Benedict | President and CEO | Buy | 15,000 | $3.14 | $47.1K | 47,500 | |
| WEAVER GREGORY L | Chief Financial Officer | Buy | 10,000 | $3.15 | $31.5K | 38,078 | |
| Durso Jerome Benedict | President and CEO | Buy | 20,000 | $3.54 | $70.8K | 32,500 | |
| WEAVER GREGORY L | Chief Financial Officer | Buy | 5,000 | $3.54 | $17.7K | 28,078 | |
| Pisano Wayne | Director | Buy | 5,000 | $4.08 | $20.4K | 13,498 | |
| Sohn Catherine A. | Director | Buy | 500 | $4.24 | $2.1K | 1,500 | |
| Jorkasky Diane | Director | Buy | 527 | $3.80 | $2.0K | 527 | |
| GILL JOHN | Director | Buy | 12,500 | $4.10 | $51.3K | 12,500 | |
| Durso Jerome Benedict | Director | Buy | 12,500 | $4.13 | $51.6K | 12,500 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.